Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 27 Clinical Trials
ID/Name Source Type
[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)
NCT02621606 clinicaltrials.gov Clinical Trial
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
NCT03316898 clinicaltrials.gov Clinical Trial
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
NCT00870974 clinicaltrials.gov Clinical Trial
A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease
NCT01122329 clinicaltrials.gov Clinical Trial
A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain
NCT03089918 clinicaltrials.gov Clinical Trial
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
NCT01503944 clinicaltrials.gov Clinical Trial
An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
NCT00474513 clinicaltrials.gov Clinical Trial
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning
NCT03130036 clinicaltrials.gov Clinical Trial
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )
NCT02686216 clinicaltrials.gov Clinical Trial
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
NCT00265148 clinicaltrials.gov Clinical Trial